Intravenous nutrition in critically ill patients should be delayed, study finds

June 6, 2011 in Other

Patients in the intensive care unit who do not tolerate adequate nutrition from tube feeding should wait a week before receiving intravenous (IV) feeding because, compared with early IV feeding, it enhances recovery from critical illness. Results of a new multicenter study from Belgium will be presented Saturday at The Endocrine Society's 93rd Annual Meeting in Boston.

"These findings have enormous impact for improving quality and reducing the cost of medical care for critically ill ," said the study's principal investigator, Greet Van den Berghe, MD, PhD, a professor at the Catholic University of Leuven.

Results of this large randomized, controlled clinical trial contradict European clinical guidelines on IV nutritional support in ICU patients, and lend support to American and Canadian recommendations. Van den Berghe said, "The standard of care in Europe should change."

At issue is the optimal timing to initiate parenteral (PN), also called IV feeding, in critically ill patients who are not getting enough calories through the gut by enteral nutrition, or tube feeding. To avoid ICU patients becoming weak from nutritional deficit, European experts recommend that they begin PN within two days of admission to the ICU, Van den Berghe explained. However, PN is linked to an increased frequency and severity of , or . Experts in the U.S. and Canada advise withholding PN during the first week in the ICU if patients were not malnourished before admission.

"Until now there has been no good scientific evidence to support either of the widely implemented nutritional strategies in ," she said.

This study, called the EPaNIC trial for Early Parenteral Nutrition to supplement insufficient enteral nutrition in , compared the timing of PN initiation in adults at seven ICUs in Belgium who were at risk of malnutrition. Of the 4,640 participants, 2,312 patients were randomly assigned to receive "early" PN (within 48 hours of admission), and 2,328 received "late" PN (no earlier than day 8 in the ICU). Both groups received early enteral nutrition support and insulin to target normal blood sugar levels.

The researchers found that late PN was superior to early PN, with time in the ICU a median of one day shorter. "Withholding IV nutrition for one week in the ICU, even in patients who could not be fed at all via the normal enteral route, surprisingly accelerated alive discharge from the ICU and from the hospital, without threatening their ability to function," Van den Berghe said.

Late PN also lowered the frequency of complications compared with early PN, including reducing severe infections (22.8 versus 26.2 percent, respectively), the authors reported. Also, late PN shortened the time on a ventilator and on dialysis, "thus allowing faster recovery from organ failure," and it "prevented liver function abnormalities," Van den Berghe said.

The investigator-initiated study received funding from the Fund for Scientific Research in Flanders, Belgium, the Catholic University of Leuven (GOA), and the Methusalem program from the Flemish government in Belgium. A nonrestricted grant to the Catholic University of Leuven came from Baxter Healthcare in France.

Provided by The Endocrine Society search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Researcher calls for new approach to regulating probiotics

In today's Nature scientific journal Dr. Gregor Reid, Director of the Canadian R&D Centre for Probiotics at Lawson Health Research Institute and a scientist at Western University, calls for a Category Tree system to be imp ...

Other created 8 hours ago | popularity not rated yet | comments 1 | with audio podcast

Professor conducting study to determine whether supplements help muscles grow

Nutritional supplements are often associated with athletes and body builders, but a University of Kansas professor is conducting a research project to determine whether they are in fact, effective and if they might be able ...

Other created 13 hours ago | popularity not rated yet | comments 0

Researchers develop IT solution to help disabled make better wheelchair selections

A Wayne State University researcher has introduced computer technology that makes it easier for people who need wheelchairs to select one that best suits their needs.

Other created May 23, 2012 | popularity not rated yet | comments 0

Study shows how patients use Facebook to solicit kidney donations

Loyola University Medical Center researchers are reporting one of the first studies to examine how patients and families are soliciting living kidney donors on Facebook.

Other created May 23, 2012 | popularity not rated yet | comments 0

WHO's Chan re-elected for second term

The World Health Organisation on Wednesday re-appointed Margaret Chan as its chief, who declared universal health care as her top priority.

Other created May 23, 2012 | popularity not rated yet | comments 0


'Personality genes' may help account for longevity

"It's in their genes" is a common refrain from scientists when asked about factors that allow centenarians to reach age 100 and beyond. Up until now, research has focused on genetic variations that offer a physiological advantage ...

Amino acid consumption associated with how fast cancer cells divide

For almost a century, researchers have known that cancer cells have peculiar appetites, devouring glucose in ways that normal cells do not. But glucose uptake may tell only part of cancer's metabolic story. Researchers from ...

Gene discovery points towards non-hormonal male contraceptive

A new type of male contraceptive could be created thanks to the discovery of a key gene essential for sperm development.

Brentuximab vedotin effective in large-cell lymphoma

(HealthDay) -- More than half of patients with relapsed or refractory systemic anaplastic large-cell lymphoma (ALCL) treated with the CD30-directed antibody-drug conjugate brentuximab vedotin achieve a complete ...

Thioridazine kills cancer stem cells in human while avoiding toxic side-effects of conventional cancer treatments

A team of scientists at McMaster University has discovered a drug, thioridazine, successfully kills cancer stem cells in the human while avoiding the toxic side-effects of conventional cancer treatments.

Cyber exercise partners help you go the distance: Motivation gains can double

A new study testing the benefits of a virtual exercise partner shows the presence of a moderately more capable cycling partner can significantly boost the motivation – by as much as 100 percent – ...